Brastib

Brastib is an oral medication containing Lapatinib, used to treat certain types of cancer. This pharmaceutical is manufactured by Stada Arzneimittel AG and is intended for oral use.

Brastib, containing the active ingredient Lapatinib, is commonly used in the treatment of specific types of cancer. It is often prescribed for patients who have certain forms of breast cancer that have spread to other parts of the body. Lapatinib works by targeting specific proteins involved in cancer cell growth, helping to slow down or stop the progression of the disease. Patients may wonder, 'What is Brastib used for?' and the primary use is in the management of advanced breast cancer.

When taking Brastib, patients may experience a range of effects. Common side effects can include diarrhea, rash, nausea, and fatigue. Some individuals might also experience more severe side effects, such as liver problems or changes in heart function. It is important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Brastib should be handled with care and stored according to the manufacturer's instructions. It is crucial to follow the prescribed dosage and administration guidelines provided by a healthcare professional. Patients with a history of liver or heart problems should discuss this with their doctor before starting treatment. Always inform healthcare providers about any other medications being taken to avoid potential interactions.

Brastib can interact with a variety of other medications, including certain antidepressants, antifungal drugs, and antibiotics. It is important to avoid grapefruit and grapefruit juice while taking Brastib, as they can affect how the body processes the medication. Patients should also be cautious with alcohol, as it may exacerbate certain side effects. Always consult a healthcare provider for personalized advice on managing potential interactions.